1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Oncologic Disorders: new trials by email Literature Review of Oncologic Disorders trials Research Report on Oncologic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types [18F]AlF-FAPI-74 PET/CT - Oesophageal Cancer, Gastric Cancer | Phase 2 / Phase 3 | Recruiting | KU Leuven | 109 | 2025-02-06 | 2026-11-06 |
| Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients Vancomycin Oral Capsule, Placebo Oral Capsule - Clostridium Difficile Infection, Hematologic Diseases | Phase 2 | Completed | Medical College of Wisconsin | 9 | 2018-06-01 | 2026-04-15 |
Clostridium Infections (1) · Esophageal Neoplasms (1) · Hematologic Diseases (1) · Neoplasms (1) · Stomach Neoplasms (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Gram-Positive Bacterial Infections (1) · Head and Neck Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Neoplasms by Site (1) · Stomach Diseases (1)
Vancomycin (1)
KU Leuven (1) · Medical College of Wisconsin (1)
Belgium (1) · United States (1)
Silvia Munoz-Price, M.D., Ph.D. (1)